Development Milestone: Mithra announces top-line results for COVID-19 estrogen study
β-lactamase Inhibitors: time for stand-alone agents?
FDA Challenges: Reputation and Results
Genomics Nation: A benchmark of the size and strengths of the UK genomics sector
Parkinson’s Update: Therapies targeted at augmenting striatal dopamine, the old and the new
Development Milestone: AVANA announce results from a Phase III trial in patients with Non-Squamous Non-Small-Cell Lung Cancer
A Day in the Life of… an Oxford University Student
tranScrip congratulates UCB on receiving positive CHMP opinion recommending approval of BIMZELX[®*] (bimekizumab) in the EU